Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors
Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
[PDF][PDF] Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors
F Alemana, N Tzarumb, L Kongb, K Nagya, J Zhua… - researchgate.net
Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors
F Aleman, N Tzarum, L Kong, K Nagy… - Proceedings of the …, 2018 - ui.adsabs.harvard.edu
Hepatitis C virus (HCV) infects 1-2% of the world's population, but a vaccine to limit
spreading of this silent killer is unavailable. A leading strategy in vaccine design to counter …
spreading of this silent killer is unavailable. A leading strategy in vaccine design to counter …
Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
F Aleman, N Tzarum, L Kong, K Nagy, J Zhu… - Proceedings of the …, 2018 - europepmc.org
Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
[PDF][PDF] Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors
F Alemana, N Tzarumb, L Kongb, K Nagya, J Zhua… - PNAS, 2018 - academia.edu
Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
[HTML][HTML] Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors
F Aleman, N Tzarum, L Kong, K Nagy… - Proceedings of the …, 2018 - ncbi.nlm.nih.gov
Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors
F Aleman, N Tzarum, L Kong, K Nagy, J Zhu… - Proceedings of the …, 2018 - JSTOR
Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors
F Aleman, N Tzarum, L Kong… - Proceedings of the …, 2018 - pubmed.ncbi.nlm.nih.gov
Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors
F Aleman, N Tzarum, L Kong, K Nagy, J Zhu… - Proceedings of the …, 2018 - cir.nii.ac.jp
抄録< jats: title> Significance</jats: title>< jats: p> Hepatitis C virus (HCV) infects 1–2% of the
world's population, but a vaccine to limit spreading of this silent killer is unavailable. A …
world's population, but a vaccine to limit spreading of this silent killer is unavailable. A …
Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors
F Aleman, N Tzarum, L Kong, K Nagy, J Zhu… - Proceedings of the …, 2018 - osti.gov
Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …
design against antigenically diverse pathogens. Here, we studied a panel of monoclonal …